This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

NCT07442110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2026-03-04

No results posted yet for this study

Summary

This observational study evaluates the clinical outcomes of patients with diabetes who utilize a specialized dietary supplements for foot ulcer healing. The study documents the rate of complete wound closure and the prevention of lower extremity amputations in a real-world, at-home setting.

Conditions

  • Limb Salvage
  • Diabetes Complication
  • Dietary Supplements
  • Healed Ulcer
  • Wound Closure
  • At Home Setting
  • Diabetes Mellitus, Type 1, Type 2
  • Wound Healing
  • Diabetic Foot Ulcer

Interventions

DIETARY_SUPPLEMENT

Diabetic foot ulcer treatment by dietary supplements

Intervention Type: Dietary Supplement Intervention Name: Diabetic Foot Ulcer Nutritional Protocol Description: A specific regimen of daily dietary supplements designed to support metabolic health and accelerated tissue repair in diabetic patients. The protocol involves the administration of targeted nutrients known to enhance collagen synthesis, reduce systemic inflammation.Participants consume the supplements orally on a daily basis over a 6-week period. The observation focuses on the supplement's ability to facilitate complete wound closure (epithelialization) and salvage limbs in patients previously scheduled for amputation. Study Status: Completed (s

Sponsors & Collaborators

  • Self funded

    collaborator UNKNOWN
  • Amar h Zireg

    lead OTHER

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-05
Primary Completion
2025-09-02
Completion
2025-09-30

Countries

  • Algeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07442110 on ClinicalTrials.gov